Table 1.
Baseline demographic and clinical characteristics for patients who developed sequential neovascular age-related macular degeneration
| Characteristic | |
|---|---|
| Age at diagnosis, years | |
| First eye, mean (SD) | 81.6 (8.0) |
| Median (range) | 83 (60–94) |
| Second eye, mean (SD) | 82.8 (8.1) |
| Median (range) | 84 (60–96) |
| Sex, n (%) | |
| Female | 34 (65.4) |
| Race, n (%) | |
| White (non-Hispanic) | 50 (96.1) |
| First treated eye, n (%) | |
| Right eye | 25 (48.1) |
|
Time between diagnosis of the first and second eye, days |
|
| Mean (SD) | 440 (328) |
| Median (range) | 362 (32–1356) |
|
Disease severity in fellow eye at first eye diagnosis, n (%) | |
| Early | 12 (23.1) |
| Intermediate | 36 (69.2) |
| Advanced | 4 (7.7) |
| Sociomedical characteristic, n (%) | |
| Nutritional supplement use1 | 38 (73.1)2 |
| Active smoker | 2 (3.8) |
| Former smoker | 16 (30.8) |
| No smoking history | 34 (65.4) |
| Family history of AMD | 18 (34.6) |
1Includes use of Age-Related Eye Disease Study (AREDS) and/or AREDS 2 vitamins, or their equivalent. 2Two additional Patients started AREDS 2 vitamins by the time of second eye conversion